We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBM
3251
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$191K ﹤0.01%
10,733
-1,440
-12% -$20.7K
EXK
3252
Endeavour Silver
EXK
$2.83B
$190K ﹤0.01%
92,734
-8,100
-8% -$16.5K
GYLD icon
3253
Arrow Dow Jones Global Yield ETF
GYLD
$37.5M
$190K ﹤0.01%
11,643
+1,062
+10% +$17.4K
NBR icon
3254
Nabors Industries
NBR
$1.21B
$190K ﹤0.01%
1,308
-1,268
-49% -$202K
DCH
3255
Dauch Corp
DCH
$1.51B
$189K ﹤0.01%
14,806
MCHP icon
3256
CALL
Microchip Technology
MCHP
$46B
$189K ﹤0.01%
275,000
-10,400
-4% -$462K
BCOV
3257
DELISTED
Brightcove, Inc.
BCOV
$189K ﹤0.01%
18,300
PVL
3258
Permianville Royalty Trust
PVL
$57.1M
$187K ﹤0.01%
70,400
BAF
3259
DELISTED
BLACKROCK MUNICIPAL INCOME INVESTMENT QUALITY TRUST
BAF
$186K ﹤0.01%
+13,042
New +$184K
DBB icon
3260
Invesco DB Base Metals Fund
DBB
$315M
$184K ﹤0.01%
11,888
+1,477
+14% +$23.6K
IGD
3261
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$517M
$184K ﹤0.01%
28,164
+3,338
+13% +$21.6K
NWSA icon
3262
News Corp Class A
NWSA
$15.4B
$184K ﹤0.01%
13,609
+3,210
+31% +$39.2K
SRV
3263
NXG Cushing Midstream Energy Fund
SRV
$216M
$184K ﹤0.01%
4,497
-738
-14% -$30.1K
WIT icon
3264
Wipro
WIT
$20B
$184K ﹤0.01%
85,148
-5,270
-6% -$11.6K
ACHN
3265
DELISTED
Achillion Pharmaceuticals
ACHN
$183K ﹤0.01%
68,415
-7,000
-9% -$20.7K
ZF
3266
DELISTED
Virtus Total Return Fund Inc.
ZF
$183K ﹤0.01%
17,239
-3,375
-16% -$34.1K
HT
3267
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$182K ﹤0.01%
10,978
-1,360
-11% -$24.1K
NXJ
3268
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$179K ﹤0.01%
12,716
+531
+4% +$7.39K
SMB icon
3269
VanEck Short Muni ETF
SMB
$314M
$178K ﹤0.01%
10,068
-669
-6% -$11.8K
IMMU
3270
DELISTED
Immunomedics Inc
IMMU
$178K ﹤0.01%
12,861
-1,834
-12% -$27.6K
NORW
3271
DELISTED
Global X MSCI Norway ETF
NORW
$178K ﹤0.01%
14,598
+164
+1% +$2.06K
BX icon
3272
PUT
Blackstone
BX
$110B
$176K ﹤0.01%
27,000
+11,000
+69% +$439K
PXLW icon
3273
Pixelworks
PXLW
$41.6M
$176K ﹤0.01%
4,975
KSU
3274
CALL
DELISTED
Kansas City Southern
KSU
$176K ﹤0.01%
44,100
+11,000
+33% +$1.32M
MRCC
3275
DELISTED
Monroe Capital Corp
MRCC
$175K ﹤0.01%
15,149
+467
+3% +$5.59K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.